JB Chemicals Q3 Results | Net profit rises 22%, revenue up 14%, margin flat

Share it

EBITDA was up 14.1% to ₹254.5 crore in the third quarter of this fiscal over ₹223.1 crore year-on-year. Shares of JB Chemicals & Pharmaceuticals Ltd ended at ₹1,737.20, up by ₹23.10, or 1.35%, on the BSE.

Leave a Comment

Your email address will not be published. Required fields are marked *